Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2011 (2011), Article ID 810469, 7 pages
Research Article

Treatment of Streptozotocin-Induced Diabetic Rats with Alogliptin: Effect on Vascular and Neural Complications

1Department of Internal Medicine, University of Iowa, Iowa City, IA 52246, USA
2Department of Veterans Affairs Iowa City Health Care System, Iowa City, IA 52246, USA

Received 14 May 2011; Accepted 21 June 2011

Academic Editor: A. Veves

Copyright © 2011 Eric P. Davidson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • Ahmet Ulugol, Cagatay Oltulu, Ozgur Gunduz, Cihad Citak, Roberto Carrara, Mohammad Reza Shaqaqi, Alicia Mansilla Sanchez, and Ahmet Dogrul, “5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice,” Pharmacology Biochemistry and Behavior, vol. 102, no. 2, pp. 344–348, 2012. View at Publisher · View at Google Scholar
  • Lene Hoimark, Torben Laursen, and Jørgen Rungby, “Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes.,” Diabetes, metabolic syndrome and obesity : targets and therapy, vol. 5, pp. 295–302, 2012. View at Publisher · View at Google Scholar
  • Randhir Singh, Lalit Kishore, and Navpreet Kaur, “Diabetic Peripheral Neuropathy: Current perspective and future directions,” Pharmacological Research, 2013. View at Publisher · View at Google Scholar
  • Suat Colak, Fatime Geyikoglu, Ali Aslan, and Gulsah Yildiz Deniz, “Effects of lichen extracts on haematological parameters of rats with experimental insulin-dependent diabetes mellitus,” Toxicology and Industrial Health, vol. 30, no. 10, pp. 878–887, 2014. View at Publisher · View at Google Scholar
  • Rasha F El-Demerdash, Lamiaa N Hammad, Mohamed M Kamal, and Hala O El Mesallamy, “A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy,” Regenerative Medicine, 2015. View at Publisher · View at Google Scholar
  • Samira Tajbakhsh, Kamelya Aliakbari, Damian J. Hussey, Karen M. Lower, Anthony J. Donato, and Elke M. Sokoya, “Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes,” Journal of Diabetes Research, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Nawal M. Al-Rasheed, Nouf M. Al-Rasheed, Hala A. Attia, Maha A. Al-Amin, Hanaa N. Al-Ajmi, Iman H. Hasan, Raeesa A. Mohamad, and Nasr A. Sinjilawi, “Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy,” Pharmacology, vol. 95, no. 5-6, pp. 229–239, 2015. View at Publisher · View at Google Scholar
  • Deborah P. Lavin, Morris F. White, and Derek P. Brazil, “IRS proteins and diabetic complications,” Diabetologia, 2016. View at Publisher · View at Google Scholar
  • Daiji Kawanami, Keiichiro Matoba, Kazunori Sango, and Kazunori Utsunomiya, “Incretin-Based Therapies for Diabetic Complications: Basic Mechanisms and Clinical Evidence,” International Journal of Molecular Sciences, vol. 17, no. 8, pp. 1223, 2016. View at Publisher · View at Google Scholar
  • Eunjin Sohn, Junghyun Kim, Chan-Sik Kim, Yun Lee, and Jin Kim, “Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats,” Nutrients, vol. 8, no. 3, pp. 140, 2016. View at Publisher · View at Google Scholar
  • Rehab Mohmed El-Gharbawy, Ashraf Mahmoud Emara, and Sally El-Sayed Abu-Risha, “Zinc oxide nanoparticles and a standard antidiabetic drug restore the function and structure of beta cells in Type-2 diabetes,” Biomedicine & Pharmacotherapy, vol. 84, pp. 810–820, 2016. View at Publisher · View at Google Scholar
  • Kentaro Tsuboi, Hiroki Mizukami, Wataru Inaba, Masayuki Baba, and Soroku Yagihashi, “The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes,” Journal of Neurochemistry, vol. 136, no. 4, pp. 859–870, 2016. View at Publisher · View at Google Scholar
  • Asma S. AL-Onazi, Nouf M. AL-Rasheed, Hala A. Attia, Nawal M. AL-Rasheed, Raeesa M. Ahmed, Maha A. AL-Amin, and Coralie Poizat, “Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways,” Journal of Pharmacy and Pharmacology, 2016. View at Publisher · View at Google Scholar
  • Chan-Sik Kim, Kyuhyung Jo, Jin Sook Kim, Mi-Kyung Pyo, and Junghyun Kim, “GS-E3D, a new pectin lyase-modified red ginseng extract, inhibited diabetes-related renal dysfunction in streptozotocin-induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar